HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Portfolio Tracker
Get an update on your stocks every day. See earnings revisions, new reports and Zacks Rank changes at a glance. Click here to learn more.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

VPHM: Viropharma Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
VIROPHARMA INC (NASD)
VPHM 7.78 0.01 (0.13%) Vol.  439,624 16.00 CST

Nov 20, 2009 The Fortune Financial Global Market Perspective Review on SchnitzerSteel Industries Inc., ViroPharma Inc., T. Rowe Price Group Inc.,Cirrus Logic Inc., Veeco Instruments Inc. and Teton Energy Corp.
Nov 18, 2009 Conference Calls Today: 1-2:45 P.M. EDT
Nov 12, 2009 MicroDose Therapeutx Purchases ViroPharma Portfolio of Investigational Compounds
Nov 10, 2009 Fundamental and Technical Research for UCBI, VPHM, TSFG, VMED, LVLTand VRGY Posted on BenchmarkJournal.com Today
Oct 30, 2009 VPHM, DARA, UCBI, TROW, PTEN and LINTA Receives Analytical Coveragefrom WallStSense.com
Oct 29, 2009 ViroPharma to Present at Three November Healthcare Conferences
Oct 28, 2009 BUYINS.NET: ViroPharma (VPHM) Down After BUYINS.NET Report Predicted Weakness After Earnings
Oct 28, 2009 ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Oct 28, 2009 Conference Calls Today: 9 A.M. EDT
Oct 27, 2009 Zacks Analyst Blog Highlights: Theravance, ViroPharma, Pfizer, Johnson & Johnson and Forest Laboratories
Oct 27, 2009 BUYINS.NET: EPD, OFC, JAH, VPHM, PEI, AVA Expected To Be Lower After Earnings Releases on Wednesday
Oct 16, 2009 Viropharma Up 81% Since SmarTrend's Buy Recommendation
Oct 15, 2009 ViroPharma to Release 2009 Third Quarter Financial Results on October 28, 2009
Oct 08, 2009 Viropharma Up 80.8% Since SmarTrend's Buy Recommendation
Oct 06, 2009 Conference Calls Today: 2-2:30 P.M. EDT
 
ZACKS COMMENTARY FOR VPHM
Oct 28, 2009 Zacks Equity Research: Report for VPHM
Oct 27, 2009 Zacks Blog: Zacks Analyst Blog Highlights: Theravance, ViroPharma, Pfizer, Johnson & Johnson and Forest Laboratories
Oct 26, 2009 Zacks Blog: Theravance Earns Milestone Payment
Oct 09, 2009 Zacks Blog: Novartis Acquires Antibiotic Rights
Sep 15, 2009 Zacks Blog: Theravance on a High
Sep 01, 2009 Zacks Blog: J&J Responds to FDA
Jul 29, 2009 Zacks Blog: ViroPharma Now Riding Cinryze
Jun 29, 2009 Zacks Blog: Optimer Pharma: Promising Year Ahead
Jun 29, 2009 Zacks Blog: Zacks Bull and Bear of the Day Highlights: Strayer Education, Red Robin Gourmet Burgers, Forest Laboratories, Inc., ViroPharma and Pfizer
Jun 26, 2009 Zacks Blog: Good News for Forest Labs
Jun 04, 2009 Zacks Blog: Update on ViroPharma
Apr 30, 2009 Zacks Blog: Mixed Emotions on ViroPharma

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research